Please use this identifier to cite or link to this item:
DC FieldValue
dc.titleThe application of pharmacoinformatics in enhancing pharmaceutical care of patients with cancer
dc.contributor.authorYAP YI-LWERN KEVIN
dc.identifier.citationYAP YI-LWERN KEVIN (2011-01-17). The application of pharmacoinformatics in enhancing pharmaceutical care of patients with cancer. ScholarBank@NUS Repository.
dc.description.abstractThis research project addresses the issue of whether pharmacoinformatics can be utilised in oncology practice to enhance the pharmaceutical care of cancer patients at high risks for drug-drug interactions (DDIs) and adverse drug reactions, such as chemotherapy-induced nausea and vomiting (CINV). The main thrust of this work revolved around the creation of OncoRx, a novel oncology-specific database, which can detect DDIs of 117 anticancer drugs and 256 chemotherapy regimens with 51 psychotropic agents and 166 complementary and alternative medicines. Additionally, principal component analysis managed to identify several risk factors (histories of alcohol drinking, CINV, fatigue, gender) and anxiety symptoms (fear of dying, fear of the worst, unable to relax, hot/cold sweats, nervousness, faintness, numbness) as potential CINV predictors from a prospective, observational study. The application of pharmacoinformatics as a novel platform and strategy demonstrates its utility in improving the pharmaceutical care of cancer patients by targeting specific drug-related problems.
dc.subjectChemotherapy-induced nausea and vomiting, drug interaction database, pharmaceutical care, pharmacoinformatics, principal component analysis
dc.contributor.supervisorCHUI WAI KEUNG
dc.contributor.supervisorCHEN YU ZONG
dc.contributor.supervisorCHAN, ALEXANDRE
dc.description.degreeconferredDOCTOR OF PHILOSOPHY
Appears in Collections:Ph.D Theses (Open)

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
YapKYL.pdf3.86 MBAdobe PDF



Google ScholarTM


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.